• Profile
Close

A multicenter randomized trial to evaluate a chemical-first or electrical-first cardioversion strategy for patients with uncomplicated acute atrial fibrillation

Academic Emergency Medicine Aug 23, 2019

Scheuermeyer FX, et al. - Researchers investigated the comparative effectiveness of chemical-first and electrical-first strategies for emergency department (ED) patients with uncomplicated atrial fibrillation (AF) of less than 48 hours. At six urban Canadian centers, they randomized 84 eligible patients: 41 in the chemical-first group in which they performed chemical cardioversion with procainamide infusion, that was followed by electrical countershock if unsuccessful; and 43 in the electrical-first group, in which they performed electrical cardioversion, that was followed by procainamide infusion if unsuccessful. As per outcomes, both chemical-first and electrical-first strategies appear efficacious and safe for uncomplicated ED AF patients managed with rhythm control; however, there was a significantly shorter ED length-of-stay when an electrical-first strategy was employed.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay